These were the exact ingredients in the multivitamin used in the Harvard COSMOS trial at MGH/Brigham hospital in Boston.
This is from the supplementary material in the journal publication on the trial: Effect of multivitamin-mineral supplementation versus placebo on cognitive function:… (The American Journal of Clinical Nutrition, 2024).
The COSMOS trial demonstrated a slowing of cognitive decline and memory loss in older people, and an overall reduction in cognitive aging: ↪ Daily multivitamin slowed cognitive aging by about two years in a COSMOS meta-analysis.
You can read past posts about this trial by searching the group for the tag #cosmosHD.
The first column shows the multivitamin used in COSMOS.
The second column shows the multivitamin used in the Physician’s Health Study II randomized trial, which demonstrated an 8% reduction in cancer rates compared to placebo: ↪ Physicians' Health Study II: a basic multivitamin cut total cancer 8% over 14 years.
All the ingredients are close to the RDA, except B12 which is 10x the RDA. Given the known neurological benefits of B12, it is hard not to suspect that the 10x RDA dose played an outsized role in the results: ↪ Even 'normal' vitamin B12 may be too low for older brains; active B12 tied to lesions.
#cosmosHD #multivitaminHD #vitaminb12HD #brainHD #memoryHD #agingHD #longevityHD



